CTSH Form 4: Director Joseph Velli Receives 12.3818 RSUs
Joseph M. Velli, a director of Cognizant Technology Solutions Corp. (CTSH), received 12.3818 restricted stock units (RSUs) on 08/26/2025 as dividend equivalent rights on previously outstanding RSUs.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Joseph M. Velli, a director of Cognizant Technology Solutions Corp. (CTSH), received 12.3818 restricted stock units (RSUs) on 08/26/2025 as dividend equivalent rights on previously outstanding RSUs. Each RSU represents a contingent right to one share of Class A common stock. Following the award, Mr. Velli beneficially owns 2,875.3818 shares (direct). The newly granted RSUs carry no cash price and are scheduled to vest in full on June 3, 2026.
Positive
- Director received additional equity alignment via 12.3818 RSUs, which may further align interests with shareholders
- Clear vesting schedule disclosed: RSUs vest fully on June 3, 2026, providing transparency on timing of potential share issuance
Negative
- None.
Insights
TL;DR: Routine dividend-equivalent award to a director increases direct holdings modestly and vests next year.
The filing documents a non-cash grant of 12.3818 restricted stock units arising from accrued dividend equivalents on existing RSUs. This is a standard compensation-related issuance to a director and does not reflect an open-market purchase or sale. The award increases direct beneficial ownership to 2,875.3818 shares and vests on June 3, 2026, aligning with typical long-term incentive practices.
TL;DR: Small, routine grant with limited immediate market impact; future share delivery contingent on vesting.
The transaction code indicates acquisition via grant rather than market activity. The size of the award (12.3818 RSUs) is immaterial relative to total outstanding shares and the filing shows no exercise price. Shares are contingent until vesting, so any impact on outstanding shares or dilution awaits settlement upon vest date.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Units | 12.3818 | $0.00 | $0.00 |
Footnotes (2)
- F1. Reflects restricted stock units received pursuant to dividend equivalent rights accrued on previously outstanding restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock of the Company.
- F2. The restricted stock units will vest fully on June 3, 2026.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What change in ownership did Joseph M. Velli report on the Form 4 for CTSH?
When were the RSUs reported for CTSH granted and when do they vest?
Did the Form 4 show any cash paid for the RSUs for CTSH?
What is the nature of the securities reported in the Form 4 for CTSH?
Does this Form 4 indicate any open-market purchases or sales by the director for CTSH?
AI-generated analysis. How Rhea-AI works. Not financial advice.